Browsing by Author "Ramgobin, Devyani"

Now showing 1 - 3 of 3
  • Thumbnail Image
    Item
    Cardiac amyloidosis‐A review of current literature for the practicing physician
    (Wiley, 2021-03) Ash, Samantha; Shorer, Eran; Ramgobin, Devyani; Vo, Maique; Gibbons, Jonathan; Golamari, Reshma; Jain, Rahul; Jain, Rohit; Medicine, School of Medicine
    The amyloidoses are a family of diseases in which misfolded precursor proteins aggregate to form amyloid and deposit in body tissues. A very serious yet underrecognized form of this disease is cardiac amyloidosis, in which amyloid deposits into the extracellular space of the myocardium, resulting in thickening and stiffening of ventricular walls with resultant heart failure and conductive dysfunction. This review provides a discussion of the pathogenesis and clinical presentation of cardiac amyloidosis subtypes, as well as an up-to-date approach to diagnosis and treatment. Significant progress has been made in recent years regarding diagnosis and treatment of this condition, but prognosis remains heavily reliant on early detection of the disease. Two types of precursor protein are responsible for most cardiac amyloidosis cases: transthyretin amyloid, and immunoglobulin-derived light chain amyloid. An early diagnosis of cardiac amyloidosis can allow for novel treatment modalities to be initiated with the potential to improve prognosis.
  • Thumbnail Image
    Item
    Congestive heart failure clinics and telemedicine: The key to reducing hospital readmissions in the United States
    (VM Media Group, 2022) Ramgobin, Devyani; Vo, Maique; Golarmari, Reshma; Jain, Rahul; Jain, Rohit; Medicine, School of Medicine
    The United States healthcare system currently faces an economic challenge related to frequent hospital readmission rates. As such, hospitals have begun implementing strategies to reduce readmission rates for specific medical conditions such as congestive heart failure, which had a 30-day readmission rate of 23.2% in 2014. Patient education and frequent monitoring of symptoms have since allowed patients to work together with doctors and nurses to take charge of their healthcare management. Due to heart failure clinics and the rise of telemedicine and telemonitoring, heart failure readmission rates have since decreased.
  • Thumbnail Image
    Item
    Current Management Guidelines on Hyperlipidemia: The Silent Killer
    (Hindawi, 2021-07-31) Su, Lilly; Mittal, Rea; Ramgobin, Devyani; Jain, Rahul; Jain, Rohit; Medicine, School of Medicine
    Given the high incidence of cardiovascular events in the United States, strict control of modifiable risk factors is important. Pharmacotherapy is helpful in maintaining control of modifiable risk factors such as elevated lipids or hypercholesterolemia. Hypercholesterolemia can lead to atherosclerotic disease which may increase the risk of acute coronary events. Statin therapy has long been a mainstay in the treatment of hypercholesterolemia, but while highly regarded, statin therapy also has side effects that may lead to patient noncompliance. Therefore, various medicines are being developed to manage hypercholesterolemia. This paper will discuss the role that lipids play in the pathophysiology of atherosclerotic disease, review the current lipid management guidelines, and discuss new treatment options that are alternatives to statin therapy.